This document discusses the manipulation of blood and blood components, commonly known as "blood doping", to artificially enhance oxygen transportation and delivery in athletes. Blood doping involves techniques like autologous blood transfusions and recombinant human erythropoietin to increase red blood cell counts and oxygen transport capacity. While it can improve endurance and performance in aerobic sports, blood doping also carries health risks like heart attacks, strokes, and blood-borne infections. The document examines who uses blood doping, the potential benefits and harms, and concludes that it is still utilized today despite anti-doping regulations.